EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The criteria for chronic rhinosinusitis in children with cystic fibrosis are rarely fulfilled after initiation of CFTR modulator treatment

Magne Bech iD, Marianne Skov iD, Ida S B Andersen, Christian von Buchwald iD, Kasper Aanæs

APMIS · 2024

DOI: 10.1111/apm.13427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, 2024. Verfasst von Magne Bech und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Rhinosinusitis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The vast majority of people with cystic fibrosis (pwCF) have untreated secondary chronic rhinosinusitis (CRS). Whereas the introduction of the cystic fibrosis transmembrane conductance regulator modulator (CFTRm) treatment regime has improved the lung function of pwCF, few studies have been published examining the effect on sinonasal symptoms in children. Our aim was to explore the effect of double CFTRm treatment on CRS and olfaction in children with CF. pwCF were included in this non‐randomized cross‐sectional study, where an otolaryngologist performed a complete ENT examination before initiating treatment with elaxacaftor/tezacaftor/ivacaftor (ETI). Twenty‐three pwCF aged 6–12 years were included. Eighteen of 23 patients were on a double CFTRm treatment, and 5 patients were CFTRm naive, respectively. Altogether, 19 had normal olfaction, 20 had none or mild CRS symptoms according to SNOT‐22, and 14 had a normal endoscopy. None of the patients had symptoms of chronic rhinosinusitis lasting for more than 12 weeks, thus none of the patients fulfilled the criteria for CRS. Children with CF treated with double CFTRm have few to no symptoms of CRS and normal olfaction, which is an improvement compared with children following treatment modalities prior to CFTRm.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorRhinosinusitisChildFemaleHumansMaleAminophenolsChronic DiseaseCross-Sectional StudiesDrug CombinationsQuinolones

Stichwörter der Autor:innen

CFTR modulatorsCystic fibrosischildrenchronic rhinosinusitissinonasal outcome test

Substanzen

AminophenolsCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorDrug CombinationsQuinolones

Autor:innen und Institutionen

  • Department of Otolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet, Copenhagen, Denmark.
  • Department of Children and Adolescents, CF Centre Copenhagen, Paediatric Pulmonary Service, Rigshospitalet, Copenhagen, Denmark.

ORCID-Profile: Magne Bech, Marianne Skov, Christian von Buchwald

Zitieren

APA

Bech, M., Skov, M., Andersen, I. S. B., von Buchwald, C., & Aanæs, K. (2024). The criteria for chronic rhinosinusitis in children with cystic fibrosis are rarely fulfilled after initiation of CFTR modulator treatment. APMIS. https://doi.org/10.1111/apm.13427

Vancouver

Bech M, Skov M, Andersen ISB, von Buchwald C, Aanæs K. The criteria for chronic rhinosinusitis in children with cystic fibrosis are rarely fulfilled after initiation of CFTR modulator treatment. APMIS. 2024. doi:10.1111/apm.13427

BibTeX
@article{Bech2024,
  author = {Bech, Magne and Skov, Marianne and Andersen, Ida S B and von Buchwald, Christian and Aanæs, Kasper},
  title = {The criteria for chronic rhinosinusitis in children with cystic fibrosis are rarely fulfilled after initiation of CFTR modulator treatment},
  journal = {APMIS},
  year = {2024},
  doi = {10.1111/apm.13427}
}
Kostenlos starten →